Cramer's lightning round: Buy Vertex Pharmaceuticals
By Alexa Lomonaco
Published on April 17, 2026.
The CNBC CEO, Jim C.
, has made his decision to buy Vertex Pharmaceuticals, stating that he wishes he had bought it for the Charitable Trust a long time ago, but got cold feet when he realized it was too difficult for the company. He also mentioned the difficulty of the industry, particularly in the pharmaceutical industry, and noted that the company had a tendency to run too high.
Read Original Article